Learn from the Experts, On Demand

Two sisters, two outcomes: explore how family screening enabled pre-symptomatic gene therapy for one, while diagnostic delay excluded the other from treatment

Spotting MLD at the stagnation phase—before irreversible damage—is critical. Red flags, gene therapy timing, and the case for newborn screening explained.

Learn the stepwise MPS diagnostic pathway—from urinary GAG analysis to enzyme and genetic testing—illustrated through a case of years-long delayed diagnosis.

Explore how GAG accumulation drives MPS pathology beyond simple storage, and why early diagnosis and multidisciplinary care can halt the damage cascade.

Discover how sibling case comparisons reveal easily missed MPS red flags, and why structured diagnostic tools speed up correct diagnosis.

Discover how GAG type guides MPS diagnosis, why gibbous deformity is a key early clue, and how newborn screening is transforming detection and outcomes.

Compare MLD treatment options—HSCT, gene therapy, and intrathecal ERT—and learn why pre-symptomatic treatment and newborn screening are so critical.

Examine Metachromatic Leukodystrophy (MLD) through an expert-led case study, emphasizing early detection, progression, and intervention strategies.

Discover how two real cases, misread as flat feet and dyspraxia, reveal why early neurological exams remain the most effective tool for catching MLD in time

Learn how MLD mimics ADHD, autism, and CIDP, why MRI and early recognition matter, and how newborn screening pilots aim to catch cases before symptoms start.

Follow one woman's decades-long diagnostic delay alongside Missouri's newborn screening success, showing how early detection is reshaping MPS I outcomes.

A review on why ENT symptoms are often the earliest warning signs, how timely tube placement, hearing aids, and specialized surgery protect long term hearing.

Short stature, joint stiffness, and hernias are common attenuated MPS I clues, best caught by endocrinologists already tracking bone development on X-rays.

Explore why orthopedic complications persist in MPS even with ERT and HSCT, and why early diagnosis, MRI surveillance, and careful surgical planning matter.

Explore Pediatric Inflammatory Multisystem Syndrome (PIMS) and its link to SARS-CoV-2 in children, covering early recognition and effective management.

Explore the gaps in transitioning MPS patients from pediatric to adult care, and international models bridging medical, psychosocial, and educational needs.

Discover how ERT falls short on CNS and bone involvement in MPS, and emerging therapies, from intrathecal delivery to gene therapy, aiming to close that gap.

Learn practical, compassionate ways pediatricians can support the psychological wellbeing of families living with chronic illness like MPS.

A diiscussion on pediatricians' long-term role in MPS care, emphasizing multidisciplinary collaboration beyond specialist intervention.

A rare glimpse into life with MPS, sharing personal experiences to help pediatricians understand affected families.